Morning Market Losers
October 17, 2014 at 10:03 AM EDT
Repros Therapeutics (NASDAQ: RPRX) shares dropped 39.53% to $6.36 following announcement the FDA meeting will be Type C guidance meeting ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.